High doses of saw palmetto appear safe over 18 months

April 29, 2013
High doses of saw palmetto appear safe over 18 months
Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.

(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.

Noting that saw palmetto berry extracts are used as self-treatment for lower urinary tract symptoms associated with , Andrew L. Avins, M.D., M.P.H., from Northern California Kaiser-Permanente Division of Research in Oakland, and colleagues examined the safety of saw palmetto extract among 357 men participating in the for Urological Symptoms trial. During 18 months of follow-up, participants were randomized to receive 320, 640, and 960 mg daily of an ethanolic saw palmetto extract in an escalating manner at six-month intervals or to an identical-appearing placebo.

The researchers found that there were no significant between-group differences in the rates of serious or non-, changes in vital signs, findings on digital prostate examination, or rates of study withdrawal. There were also no significant differences in laboratory test abnormalities between the groups. Differences in individual laboratory tests were small in magnitude and occurred rarely. There was no evidence of a dose-response effect of saw palmetto.

"Our data suggest that saw palmetto is unlikely to be associated with important, common toxicity for up to 18 months," write the authors. "While the most recent clinical evidence does not support the superiority of saw palmetto over placebo, it appears that men who elect to try the supplement are unlikely to have substantial adverse medical consequences from short-term use."

Placebo and saw palmetto extract were provided by Rottapharm/Madaus. One author disclosed to the Informed Medical Decisions Foundation.

Explore further: High doses of saw palmetto don't impact serum PSA

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

High doses of saw palmetto don't impact serum PSA

February 8, 2013
(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research published in ...

Popular supplement - saw palmetto extract - has no effect on prostate health: study

September 27, 2011
The most widely used over-the-counter supplement for prostate health is no more effective than a placebo in treating men's lower urinary tract symptoms.

Eating smart: Researcher studies foods, dietary supplements that may reduce risk of prostate cancer

January 23, 2012
A Kansas State University professor is turning to nutrition to tackle prostate cancer.

Latrepirdine not effective in Huntington's disease

November 1, 2012
(HealthDay)—Although safe and well tolerated, the experimental small molecule latrepirdine does not improve cognition after six months of treatment in patients with mild-to-moderate Huntington's disease (HD), according ...

Belimumab deemed safe for long-term lupus treatment

June 19, 2012
(HealthDay) -- For patients with systemic lupus erythematosus (SLE), long-term belimumab therapy combined with standard therapy is well tolerated, according to a study published online June 5 in Arthritis & Rheumatism.

Sumatriptan/Naproxen helpful in treating teens' migraines

May 15, 2012
(HealthDay) -- Treatment with sumatriptan and naproxen sodium (suma/nap) is well tolerated and effective in reducing migraine pain in adolescents, according to a study published online May 14 in Pediatrics.

Recommended for you

Onions could hold key to fighting antibiotic resistance

January 22, 2018
A type of onion could help the fight against antibiotic resistance in cases of tuberculosis, a UCL and Birkbeck-led study suggests.

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.